Intrusion Inc

Company INTZ

Last mentioned: Mar 24, 2026

Stories mentioning Intrusion Inc 2

pharma Neutral

TELA Bio Reports 2025 Results as Soft Tissue Reconstruction Market Shifts

TELA Bio reported its fourth-quarter and full-year 2025 financial results, highlighting the steady adoption of its OviTex reinforced tissue matrices. The report comes amid a busy earnings cycle that also saw leadership changes at Reed's Inc. and financial updates from Intrusion Inc.

Mar 24, 2026 3 sources

market-trends Neutral

TELA Bio and Intrusion Inc. Lead Q4 2025 Earnings in MedTech and Cybersecurity

TELA Bio and Intrusion Inc. reported their Q4 and full-year 2025 financial results, highlighting growth in soft tissue reconstruction and advanced cybersecurity solutions. These reports, alongside a leadership transition at Reed's Inc., underscore the evolving landscape of medical technology and data protection in the healthcare sector.

Mar 24, 2026 3 sources